Profil
Daniel A. Simon is Chief Business Officer at IDEAYA Biosciences, Inc. since 2024.
Formerly, Chief Business Officer at Revolution Medicines, Inc. from 2022 to 2024.
Senior VP-Biopharma Business Development at Guardant Health, Inc. from 2015 to 2022.
Education includes graduate studies at the University of Cambridge and an MBA from The Wharton School of the University of Pennsylvania.
Postes actifs de Daniel Simon
| Sociétés | Poste | Début |
|---|---|---|
| IDEAYA BIOSCIENCES, INC. | Corporate Officer/Principal | 01/08/2024 |
Anciens postes connus de Daniel Simon
| Sociétés | Poste | Fin |
|---|---|---|
| REVOLUTION MEDICINES, INC. | Corporate Officer/Principal | 01/01/2024 |
| GUARDANT HEALTH, INC. | Corporate Officer/Principal | 01/01/2022 |
Formation de Daniel Simon
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Guardant Health, Inc.
Guardant Health, Inc. Medical SpecialtiesHealth Technology Develops blood and tissue test devices to detect cancer & provides related screening services | Health Technology |
University of Cambridge
University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Revolution Medicines, Inc.
Revolution Medicines, Inc. Pharmaceuticals: OtherHealth Technology Develops new therapies derived from natural products | Health Technology |
IDEAYA Biosciences, Inc.
IDEAYA Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as oncology-focused precision medicine company which develops and sells cancer therapeutics | Health Technology |
















